Mircera 50mcg, 75mcg, 100mcg (SC & IV) Methoxy polyethylene glycol-epoetin beta
Intended for healthcare professionals only
This material should not be used as a substitute for professional medical advice or to promote any medication. For more information, please consult your physician.
Mircera contains the active substance methoxy polyethylene glycol epoetin beta, and is a medicine that stimulates the growth of red blood cells. It is indicated for the treatment of symptomatic anemia associated with chronic kidney disease (CKD) in adult patients, and in pediatric patients 5 to 17 years of age on hemodialysis who are converting from another ESA after their hemoglobin level was stabilized with an ESA. It is given by subcutaneous or intravenous injections, using a pre-filled syringe.
Full prescribing information is available on request.
If you have a scientific query related to one of Roche's products, please contact us at [email protected]
In case of any adverse events or safety queries, please contact [email protected]
M-PK-00002297
Solutions